← SynDRA
TRACAZOLATE
SynDRA canonical compound SYN0003478 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GABRA1 |
|---|
| Mechanism of action | GABA receptor modulator |
|---|
All known targets
Mechanisms of action (all sources)
- GABA receptor modulator
- GABRD AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ATAD5
- USP1
- TSHR
- TP53
- THPO
- TDP1
- SMN1
- SAMHD1
- RGS4
- PMP22
- NPSR1
- MPHOSPH8
- MAPT
- MAPK1
- LMNA
- KCNH2
- HSD17B10
- HDAC6
- GPR68
- GMNN
- EHMT2
- DRD1
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- CREBBP
- CBX1
- BLM
- USP2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- ANDR
- CP1A2
- CP2C9
- CP2D6
- CP3A4
- CP3A7
- ESRRA
- GLI3
- GPR32
- KMT2A
- MEN1
- NR1I2
- NTM1A
- NTMT1
- PRGR
Cross-references
Synonyms
- Tracazolato
- ICI 136,753
- ICI-136753
- ICI-136,753
- Tracazolatum
- ICI 136753
- NH0HPL3U1T
- RefChem:933237
- DTXCID1026956
- NCGC00015985-03
- UNII-NH0HPL3U1T
- Tracazolatum [INN-Latin]
- Tracazolato [INN-Spanish]
- Tracazolate [USAN:INN:BAN]
- EINECS 255-214-9
- Tocris-1558
- Lopac-T-112
- Prestwick0_000976
- Prestwick1_000976
- Prestwick2_000976
- Prestwick3_000976
- TRACAZOLATE [INN]
- Tracazolate (USAN/INN)
- TRACAZOLATE [USAN]
- Lopac0_001263
- BSPBio_001011
- MLS000860035
- SCHEMBL114769
- SPBio_002922
- BPBio1_001113
- GTPL5467
- orb2814733
- Tracazolate, analytical standard
- BDBM82043
- CHEBI:92596
- BRD4330
- HMS2233P22
- HMS3260E14
Look up TRACAZOLATE in the interactive SynDRA portal →